BCL2L11 and neoplasm: miR‐221 targets among other genes BCL2L11, which exhibits pro‐apoptotic properties, thereby suppressing tumor growth (Aichberger et al., 2009), as well as the gatekeeper PTEN (Li et al., 2016).